1PIV

BINDING OF THE ANTIVIRAL DRUG WIN51711 TO THE SABIN STRAIN OF TYPE 3 POLIOVIRUS: STRUCTURAL COMPARISON WITH DRUG BINDING IN RHINOVIRUS 14


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.9 Å

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Binding of the antiviral drug WIN51711 to the sabin strain of type 3 poliovirus: structural comparison with drug binding in rhinovirus 14.

Hiremath, C.N.Grant, R.A.Filman, D.J.Hogle, J.M.

(1995) Acta Crystallogr.,Sect.D 51: 473-489

  • DOI: 10.1107/S090744499401084X

  • PubMed Abstract: 
  • The crystal structure of the Sabin strain of type 3 poliovirus (P3/Sabin) complexed with the antiviral drug WIN51711 has been determined at 2.9 A resolution. Drugs of this kind are known to inhibit the uncoating of the virus during infection, by stab ...

    The crystal structure of the Sabin strain of type 3 poliovirus (P3/Sabin) complexed with the antiviral drug WIN51711 has been determined at 2.9 A resolution. Drugs of this kind are known to inhibit the uncoating of the virus during infection, by stabilizing the capsid against receptor-induced conformational changes. The electron density for the bound drug is very well defined so that its position and orientation are unambiguous. The drug binds in a nearly extended conformation, slightly bent in the middle, in a blind pocket formed predominantly by hydrophobic residues in the core of the beta-barrel of capsid protein VP1. Comparisons between this structure, the corresponding drug complex in human rhinovirus 14 (HRV 14), and the native structures of both viruses demonstrate that the binding of WIN51711 has markedly different effects on the structures of these two viruses. Unlike HRV14, wherein large conformational changes are observed in the coat protein after drug binding, the binding of this drug in poliovirus does not induce any significant conformational changes in the structure of the capsid protein, though the drug has a greater inhibitory effect in P3/Sabin than in HRV14. The implications of this result for the mechanism of capsid stabilization are discussed.


    Related Citations: 
    • Structures of Poliovirus Complexes with Anti-Viral Drugs: Implications for Viral Stability and Drug Design
      Grant, R.A.,Hiremath, C.N.,Filman, D.J.,Hogle, J.M.
      (1994) Curr.Biol. 4: 784
    • Role of Conformational Transitions in Poliovirus Assembly and Cell Entry
      Hogle, J.M.,Syed, R.,Fricks, C.E.,Icenogle, J.P.,Flore, O.,Filman, D.J.
      (1990) New Aspects of Positive-Strand RNA Viruses --: 199
    • Structural Factors that Control Conformational Transitions and Serotype Specificity in Type 3 Poliovirus
      Filman, D.J.,Syed, R.,Chow, M.,Macadam, A.J.,Minor, P.D.,Hogle, J.M.
      (1989) Embo J. 8: 1567
    • The Nucleotide Sequence of Poliovirus Type 3 Leon 12A1B: Comparison with Poliovirus Type 1
      Stanway, G.,Cann, A.J.,Hauptman, R.,Hughes, P.,Clarke, L.D.,Mountford, R.C.,Minor, P.D.,Schild, G.C.,Almond, J.W.
      (1983) Nucleic Acids Res. 11: 5629


    Organizational Affiliation

    Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
POLIOVIRUS TYPE 3 (SUBUNIT VP1)
0
4N/AN/A
Protein Feature View is not available: No corresponding UniProt sequence found.
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
POLIOVIRUS TYPE 3 (SUBUNIT VP1)
1
301Poliovirus type 3 (strains P3/Leon/37 and P3/Leon 12A[1]B)EC: 3.6.1.15, 3.4.22.28, 3.4.22.29, 2.7.7.48
Find proteins for P03302 (Poliovirus type 3 (strains P3/Leon/37 and P3/Leon 12A[1]B))
Go to UniProtKB:  P03302
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetails
POLIOVIRUS TYPE 3 (SUBUNIT VP2)
2
271Poliovirus type 3 (strains P3/Leon/37 and P3/Leon 12A[1]B)EC: 3.6.1.15, 3.4.22.28, 3.4.22.29, 2.7.7.48
Find proteins for P03302 (Poliovirus type 3 (strains P3/Leon/37 and P3/Leon 12A[1]B))
Go to UniProtKB:  P03302
Entity ID: 4
MoleculeChainsSequence LengthOrganismDetails
POLIOVIRUS TYPE 3 (SUBUNIT VP3)
3
238Poliovirus type 3 (strains P3/Leon/37 and P3/Leon 12A[1]B)EC: 3.6.1.15, 3.4.22.28, 3.4.22.29, 2.7.7.48
Find proteins for P03302 (Poliovirus type 3 (strains P3/Leon/37 and P3/Leon 12A[1]B))
Go to UniProtKB:  P03302
Entity ID: 5
MoleculeChainsSequence LengthOrganismDetails
POLIOVIRUS TYPE 3 (SUBUNIT VP4)
4
68Poliovirus type 3 (strains P3/Leon/37 and P3/Leon 12A[1]B)EC: 3.6.1.15, 3.4.22.28, 3.4.22.29, 2.7.7.48
Find proteins for P03302 (Poliovirus type 3 (strains P3/Leon/37 and P3/Leon 12A[1]B))
Go to UniProtKB:  P03302
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
MYR
Query on MYR

Download SDF File 
Download CCD File 
4
MYRISTIC ACID
C14 H28 O2
TUNFSRHWOTWDNC-UHFFFAOYSA-N
 Ligand Interaction
W71
Query on W71

Download SDF File 
Download CCD File 
1
5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE
COMPOUND IV
C20 H26 N2 O3
FKLJPTJMIBLJAV-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.9 Å
  • Space Group: I 2 2 2
Unit Cell:
Length (Å)Angle (°)
a = 321.060α = 90.00
b = 358.620β = 90.00
c = 381.820γ = 90.00
Software Package:
Software NamePurpose
X-PLORmodel building
X-PLORrefinement
X-PLORphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 1995-06-03
    Type: Initial release
  • Version 1.1: 2008-03-24
    Type: Version format compliance
  • Version 1.2: 2011-07-13
    Type: Version format compliance